NewsBenzingaTrevi Therapeutics Announces Results From Phase 2b CORAL Trial Accepted As Oral Presentation At CHEST 2026 Annual Meeting Of American College Of Chest Physicians Trevi Therapeutics Announces Results From Phase 2b CORAL Trial Accepted As Oral Presentation At CHEST 2026 Annual Meeting Of American College Of Chest Physicians Benzinga 2026.10.13 11:33 (GMT+0) Open on Benzinga Other news Dow Jones Today: DJIA Flat as Oil Edges Lower; Tech Stocks Rebound - TipRanks.com Gas Never Used To Be This Pricey In October; West Coast Imports Are Surging Wells Fargo Maintains Equal-Weight on Sonoco Products, Lowers Price Target to $53 Piper Sandler Maintains Neutral on WaFd, Lowers Price Target to $31 INTC vs. AMD: Which AI Chip Stock Could Continue to Rally After Today? - TipRanks.com VinFast Says Real Estate Could Cover Its EV Cash Burn
